Cargando…
Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study
Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors. Preventing and/or treating children suffering from recurrent respiratory tract infections (RRTIs) is challenging, and it is importa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619242/ https://www.ncbi.nlm.nih.gov/pubmed/36324817 http://dx.doi.org/10.3389/fped.2022.999701 |
_version_ | 1784821232707829760 |
---|---|
author | Rennerova, Zuzana Picó Sirvent, Leandro Carvajal Roca, Eva Paśnik, Jarosław Logar, Mateja Milošević, Katarina Majtan, Juraj Jesenak, Milos |
author_facet | Rennerova, Zuzana Picó Sirvent, Leandro Carvajal Roca, Eva Paśnik, Jarosław Logar, Mateja Milošević, Katarina Majtan, Juraj Jesenak, Milos |
author_sort | Rennerova, Zuzana |
collection | PubMed |
description | Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors. Preventing and/or treating children suffering from recurrent respiratory tract infections (RRTIs) is challenging, and it is important to provide more clinical evidence about the safety and efficacy of natural immunomodulating preparations, including β-glucans. The aim of the present study was to assess the incidence of respiratory tract infections (RTIs) in children with a history of RRTIs for a period of 6 months (3 months of pleuran supplementation and 3 months of follow-up) compared with the same period from October to March of the previous year prior to enrolment in the study. A total of 1,030 children with a mean age of 3.49 ± 1.91 years from seven countries were included in this study. The total number of RTIs observed during the study period was significantly lower compared to the same period of the previous year (7.07 ± 2.89 vs. 3.87 ± 3.19; p < 0.001). Analysis of each type of RTI revealed significant reductions in the mean number and duration of infections for all RTI subtypes compared to the previous year. This study also confirmed the beneficial safety profile of pleuran supplementation. In conclusion, pleuran supplementation represents an interesting and prospective supplement in preventing respiratory infections and reveals new strategies for supporting immune functions in the paediatric population. |
format | Online Article Text |
id | pubmed-9619242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96192422022-11-01 Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study Rennerova, Zuzana Picó Sirvent, Leandro Carvajal Roca, Eva Paśnik, Jarosław Logar, Mateja Milošević, Katarina Majtan, Juraj Jesenak, Milos Front Pediatr Pediatrics Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors. Preventing and/or treating children suffering from recurrent respiratory tract infections (RRTIs) is challenging, and it is important to provide more clinical evidence about the safety and efficacy of natural immunomodulating preparations, including β-glucans. The aim of the present study was to assess the incidence of respiratory tract infections (RTIs) in children with a history of RRTIs for a period of 6 months (3 months of pleuran supplementation and 3 months of follow-up) compared with the same period from October to March of the previous year prior to enrolment in the study. A total of 1,030 children with a mean age of 3.49 ± 1.91 years from seven countries were included in this study. The total number of RTIs observed during the study period was significantly lower compared to the same period of the previous year (7.07 ± 2.89 vs. 3.87 ± 3.19; p < 0.001). Analysis of each type of RTI revealed significant reductions in the mean number and duration of infections for all RTI subtypes compared to the previous year. This study also confirmed the beneficial safety profile of pleuran supplementation. In conclusion, pleuran supplementation represents an interesting and prospective supplement in preventing respiratory infections and reveals new strategies for supporting immune functions in the paediatric population. Frontiers Media S.A. 2022-10-14 /pmc/articles/PMC9619242/ /pubmed/36324817 http://dx.doi.org/10.3389/fped.2022.999701 Text en © 2022 Rennerova, Picó Sirvent, Carvajal Roca, Paśnik, Logar, Milošević, Majtan and Jesenak. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Rennerova, Zuzana Picó Sirvent, Leandro Carvajal Roca, Eva Paśnik, Jarosław Logar, Mateja Milošević, Katarina Majtan, Juraj Jesenak, Milos Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
title | Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
title_full | Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
title_fullStr | Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
title_full_unstemmed | Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
title_short | Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
title_sort | beta-(1,3/1,6)-d-glucan from pleurotus ostreatus in the prevention of recurrent respiratory tract infections: an international, multicentre, open-label, prospective study |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619242/ https://www.ncbi.nlm.nih.gov/pubmed/36324817 http://dx.doi.org/10.3389/fped.2022.999701 |
work_keys_str_mv | AT rennerovazuzana beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT picosirventleandro beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT carvajalrocaeva beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT pasnikjarosław beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT logarmateja beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT milosevickatarina beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT majtanjuraj beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy AT jesenakmilos beta1316dglucanfrompleurotusostreatusinthepreventionofrecurrentrespiratorytractinfectionsaninternationalmulticentreopenlabelprospectivestudy |